Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of ...

Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help ...

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

Levine Children's Hospital has several experimental treatments that help families get lifesaving care without having to leave ...

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

The U.S. Department of Labor’s Wage and Hour Division issued an opinion letter on Nov. 8, 2024, affirming that employees may use Family and ...

Neurogene (NGNE) announced an update on its ongoing Phase 1/2 open-label clinical trial evaluating NGN-401 gene therapy for the treatment of ...